UTI Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1208 Cr | ₹1150 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 28 Dec 2015 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 28% |
Expense Ratio | 2.14 | 2.22 |
Manager | Meeta Shetty | Kamal Gada |
ISIN Code | INF277K016A9 | INF789F01695 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | 2.49% | 5.44% |
6 Month | -1.68% | -0.9% |
1 Year | 13.65% | 20.88% |
3 Year | 24.87% | 26.75% |
5 Year | 21.5% | 22.01% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 4.16% | 6.95% |
1 Year | 3.59% | 10.1% |
3 Year | 23.77% | 27.46% |
5 Year | 19.49% | 20.74% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 9.47% | 11.86% |
3 Year | 18.04% | 16.19% |
5 Year | 14.89% | 14.42% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 16.538% | 16.371% |
Sharp | 0.681% | 0.731% |
Beta | 0.969% | 0.958% |
Alpha | 0.018% | 0.84% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Meeta Shetty | Kamal Gada |
Total AUM | ₹17847 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 5.06 | 1.35 |
Small Cap | 27.82 | 43.53 |
Large Cap | 35.26 | 28.87 |
Mid Cap | 31.87 | 26.26 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 4.34 | 0.45 |
Basic Materials | 2.22 | 1.33 |
Healthcare | 93.44 | 98.22 |
Top Comparisons
Kotak Flexicap Fund - Growth
3Y Returns21.59%
Parag Parikh Flexi Cap Fund Regular-Growth
3Y Returns23.48%
Franklin India Smaller Companies Fund-Growth
3Y Returns29.71%
Bandhan Small Cap Fund Regular Growth
3Y Returns34.98%
Franklin India Feeder - Franklin U.S. Opportunities Fund - Growth
3Y Returns22.75%
Axis Global Equity Alpha Fund of Fund - Regular Plan - Growth Option
3Y Returns18.57%
NIPPON INDIA QUARTERLY INTERVAL FUND SERIES II IDCW PLAN REINVESTMENT
3Y Returns6.89%
NIPPON INDIA QUARTERLY INTERVAL FUND SERIES II IDCW PLAN REINVESTMENT
3Y Returns6.89%